Dr. Christopher Thomas Martin, MD

Dr. Martin practices at Sharpe, Dillon, Cockson & Associates in Minneapolis, Minnesota.

Dr. Martin's NPI, 1679849962, was assigned on March 30, 2012. Dr. Martin holds Minnesota license 59749.

Dr. Martin's primary practice is Sharpe, Dillon, Cockson & Associates, at 7600 France S Ave, Minneapolis, MN 55435 in Hennepin County. The practice phone is (982) 428-1400.

Dr. Martin's primary practice is Sharpe, Dillon, Cockson & Associates in Minneapolis, Minnesota. Dr. Martin is also affiliated with Abbott Northwestern Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Martin to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Martin practices, 6 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Martin's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Martin is licensed in Minnesota.

CMS data shows 3,153 Medicare services from Dr. Martin across 21 procedure codes in 2024, for 282 Medicare patients. Medicare paid $88,954 for them.

CMS counts 282 Medicare patients who saw Dr. Martin in 2024. The largest group is 65 to 74, with 117 patients. 74% of them have high blood pressure, and 70% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Martin's median patient age at 64, with 68% women.

In 2024, Dr. Martin wrote 2,252 Medicare Part D claims for 324 patients. 38% of them were for generic drugs. CMS names the drug for 1,965 of them, across 40 drugs with 11 or more claims each, at $1,187,236 in total drug cost. In 2023, CMS named 1,627 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Martin for performance year 2024, reported as part of a group. Dr. Martin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Martin as offering telehealth.

CMS Open Payments shows 13 general payments to Dr. Martin from 4 drug and device companies from 2017 to 2018. Travel and lodging make up the largest share, 93% of the total. Merck Sharp & Dohme Corporation paid the most, $1,000.